Ms. Rinderle joined Bain Capital in 2022. She is a Managing Director on the Bain Capital Life Sciences team. Prior to joining Bain Capital, she was a Principal at KKR within the Healthcare Growth Equity and Private Equity teams where she focused on the life sciences. Before KKR, Ms. Rinderle was a Vice President at Longitude Capital, a healthcare venture growth firm where she focused on biopharmaceutical investments. Prior to that, she was an Analyst at Aisling Capital, a life sciences investment firm, as well as an Analyst in J.P. Morgan’s Health Care Investment Banking practice.
Ms. Rinderle holds an M.B.A. from Stanford Graduate School of Business, where she was an Arjay Miller Scholar. She received her B.S. in Biomedical Engineering with distinction from Yale University graduating magna cum laude, Tau Beta Pi, and Phi Beta Kappa.